Press Release: Cannabis Pharmaceuticals Market Report 2025-2029 and 2034 Featuring Leading Players - Curaleaf, Aphria, Green Thumb Industries, Trulieve Cannabis Corp, and Tilray
Dublin, July 29, 2025 (GLOBE NEWSWIRE) -- The "Cannabis Pharmaceuticals Market Report 2025" report has been added to ResearchAndMarkets.com's offering. The cannabis pharmaceuticals market size has grown exponentially in recent years. It will grow from $6.03 billion in 2024 to $9.45 billion in 2025 at a compound annual growth rate (CAGR) of 56.66%. The cannabis…
NEW YORK, Jan. 21, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds persons who invested in securities of SLM Corporation a/k/a Sallie Mae (NASDAQ: SLM) between July 25, 2025 and August 14, 2025, both dates inclusive (the “Class Period”), of the important February 17, 2026 lead plaintiff deadline.
LAS VEGAS, Jan. 21, 2026 (GLOBE NEWSWIRE) -- GBank Financial Holdings Inc. (the “Company”) (Nasdaq: GBFH), the parent company of GBank (the “Bank”), is pleased to announce that Jason Amos has been appointed Executive Vice President and Chief Technology Officer (EVP & CTO) of the Bank. Amos will lead the bank’s technology strategy and modernization efforts…
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Agilon (AGL) To Contact Him Directly To Discuss Their Options If you purchased or acquired Agilon securities between February 26, 2025 and August 4, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Forunato…
LOS ANGELES, Jan. 21, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
